PRY

Across TCGA pan-cancer cohorts, PRY RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated PRY data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher PRY RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PRY expression acts as an unfavorable survival marker.

THCA, LIHC, and KIRP are the cancer types where PRY RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	II,III,IV	0.146	0.842	<.001	54	view →
LIHC	OS	Tertile	III,IV	0.185	0.654	.005	45	view →
KIRP	DFS	Tertile	All	0.529	0.876	.001	39	view →
ESCA	OS	Tertile	II,III,IV	0.103	0.868	<.001	36	view →
SARC	OS	Tertile	All	0.567	0.859	.046	9	view →
KICH	OS	Tertile	All	0.844	0.965	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

PRY–THCA (DFS)

Open the THCA breakdown →